tradmap

CBT Financials Cabot Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 7.3% per year over the past 5 years.
  • Operating margin has expanded, at 16.7% in the latest year.
  • Free cash flow has grown 17.2% per year over the past 5 years.

Financial health

  • Total debt ($1.1B) exceeds cash ($258M); net debt is $848M.
  • Total debt has grown slower than revenue (0.3% vs 7.3% per year).
  • Operating income covered interest expense 8.2× in the latest year, up from 0.4× 5 years ago.
  • Total debt is 1.4× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 29.0% of earnings and 24.6% of free cash flow.
  • The dividend has grown 3.7% per year over the past 5 years.
Revenue & net income
-$334M $2B $4B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-12% 7% 25% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
-$111M $170M $451M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $712M $1B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$1B -$244M $692M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $3.7B $331M 25.3% 16.7% $391M $1.1B $258M
2024 $4.0B $380M 24.0% 15.4% $451M $1.1B $223M
2023 $3.9B $445M 21.3% 13.4% $351M $1.3B $238M
2022 $4.3B $209M 20.5% 9.0% -$111M $1.4B $206M
2021 $3.4B $250M 23.4% 13.3% $62M $1.1B $168M
2020 $2.6B -$238M 19.1% 0.8% $177M $1.1B $151M
2019 $3.3B $157M 20.5% 9.2% $139M $1.1B $169M
2018 $3.2B -$113M 23.8% 4.4% $69M $996M $175M
2017 $2.7B $248M 24.2% 12.4% $201M $915M $280M
2016 $2.4B $147M 23.8% 10.2% $280M $914M $200M
2015 $2.9B -$334M 20.4% -11.0% $358M $980M $77M
2014 $3.6B $199M 19.8% 9.2% $144M $1.1B $67M
2013 $3.5B $153M 18.3% 7.8% $155M $1.3B $95M
2012 $3.3B $388M 19.6% 8.8% $134M $1.4B $120M
2011 $3.1B $236M 18.0% 7.8% -$35M $699M $286M

Valuation over time

How the market has priced CBT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 9.5 18.9 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 0.7 1.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 1.5 3.0 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is CBT growing its revenue and profit?

Over the past 5 years, Cabot Corp's revenue has grown 7.3% per year. These are computed facts, not advice.

How much debt does CBT have?

As of FY2025, Cabot Corp reported $1.1B of total debt against $258M of cash; operating income covered interest expense 8.2×.

What is CBT's profit margin?

In FY2025, gross margin was 25.3%, operating margin 16.7%, and net margin 8.9%.

What is CBT's P/E ratio?

As of Jun '26, Cabot Corp traded at a price-to-earnings ratio of about 14.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.